A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta 4 in healthy volunteers

Synthetic thymosin beta 4 (T beta 4) may have a potential use in promoting myocardial cell survival during acute myocardial infarction. Four cohorts, with 10 healthy subjects each, were given a single intravenous dose of placebo or synthetic T beta 4. Cohorts received ascending doses of either 42, 1...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the New York Academy of Sciences 2010-04, Vol.1194 (1), p.223-229
Hauptverfasser:	Ruff, Dennis, Crockford, David, Girardi, Gino, Zhang, Yuxin
Format:	Artikel
Sprache:	eng
Schlagworte:	Beta Constraining Incidence Ischemia Myocardial infarction Safety Survival Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!